This phenomenon has also been observed in psoriasis, where TNF-α inhibitors ushered in the modern era of efficacious psoriasis therapy, yet sometimes psoriasis can developde novo in patients with another autoimmune disease like rheumatoid arthritis or inflammatory bowel disease treated with a TNF-α inhibitor. Here, TNF is linked to autoimmune disease.